Skip to content

Clinical trials

Completed Phase 1/2 Hyperlipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 1/2 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20071
20091
20171
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jiangsu HengRui Medicine Co., Ltd.1
National Center for Complementary and Integrative Health (NCCIH)1
Oregon Health and Science University1
Sapporo Health Promotion Foundation1
Shanghai Junshi Bioscience Co., Ltd.1
Temple University1
The Center for Rheumatic Disease, Allergy, & Immunology1
University of Alberta1
University of Missouri-Columbia1
University of Yaounde 11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias10
Hypertension3
Metabolic Syndrome3
Obesity3
Alzheimer Disease1
Dementia1
Diabetes Mellitus1
Diabetes Mellitus, Type 11
HIV Infections1
Hyperglycemia1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.